Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 69

Daily Deal Round Up: June 18, 2021

Behavioural health platform developer Brightline captured $72m in a round led by GV, while Gopuff is set to buy Siemens and ST-backed mobility software producer RideOS.

Jun 18, 2021

Circle Pharma draws $66m series C

The oncology therapeutics developer has added $66m to its coffers thanks to investors including Berkeley Catalyst Fund.

Jun 18, 2021

Mnemo Therapeutics redeems $91m

Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.

Jun 18, 2021

Mnemo Therapeutics redeems $91m

Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.

Jun 18, 2021

Daily Deal Round Up: June 17, 2021

11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.

Jun 17, 2021

The Pill Club swallows more series B funds

GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.

Jun 17, 2021

Daily Deal Round Up: June 16, 2021

Bitwise Asset Management completed a $70m round backed by Coinbase at a $500m-plus valuation, while luxury goods wholesaler Joor raised $46m to take its overall funding to $81m.

Jun 16, 2021

Duda develops with $50m series D

Susquehanna Growth Equity has returned to reinvest in the web design platform operator, which has amassed $100m in funding in total.

Jun 16, 2021

Camp4 collects $45m capital injection

Kraft Group has once again participated in a funding round for the RNA drug developer, having backed its series A round three years ago.

Jun 16, 2021

Sanity Group snatches series A funds

German Media Pool was among the participants in a $44.2m round that will fund the building of the cannabinoid product developer's production and research facility.

Jun 16, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here